Erythrocytic calpain-calpastatin system in Alzheimer’s disease

[1]  R. Nixon,et al.  Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[2]  E. Perry,et al.  Comparison of Ca2+-activated proteinase enzyme and endogeneous inhibitor activity in brain tissue from normal and Alzheimer's disease cases , 1991, Journal of the Neurological Sciences.

[3]  G. Lynch,et al.  Development of hippocampal long-term potentiation is reduced by recently introduced calpain inhibitors , 1990, Brain Research.

[4]  J. Card,et al.  Proteolytic processing of beta-amyloid precursor by calpain I , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[5]  K. Blomgren,et al.  Calpain and calpastatin in normal and Alzheimer-degenerated human brain tissue , 1990, Neurobiology of Aging.

[6]  D. Selkoe,et al.  [Biochemistry of Alzheimer's disease]. , 1990, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[7]  Michel Baudry,et al.  Brain spectrin, calpain and long-term changes in synaptic efficacy , 1987, Brain Research Bulletin.

[8]  E. Melloni,et al.  Decreased level of calpain inhibitor activity in red blood cells from Milan hypertensive rats. , 1986, Biochemical and biophysical research communications.

[9]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[10]  T. Murachi,et al.  [Calpain and calpastatin]. , 1983, Rinsho byori. The Japanese journal of clinical pathology.

[11]  W. Schlaepfer,et al.  Characterization of a brain calcium-activated protease that degrades neurofilament proteins. , 1982, Biochemistry.

[12]  K. Blennow,et al.  Increased Proteolytic Activity in Erythrocytes from Patients with Alzheimer's Disease , 1992 .